SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors upcoming FDA decision on deramiocel for Duchenne muscular dystrophy is driving attention, with traders focused on the November 22 target date and the companys amended application emphasizing upper-limb function data. Bullish traders interpret the longer-term data, rare-disease policy discussions and recent commercial hiring as encouraging signs, while skeptics cite prior FDA concerns and say approval remains uncertain.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCath reimbursement could fall after early 2027 has fueled a sharp selloff and concern about future pricing and revenue. Traders disagree over whether the warning signals sustained pressure or is only a preliminary estimate, pointing to CMSs more stable outlook while criticizing CorMedixs lack of clarification.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

The rally toward fresh highs is drawing attention ahead of the expected Q3 report, with traders weighing BRIUMVIs growth against unconfirmed buyout speculation and possible short-covering. Some see the move as a bet on earnings and the companys commercial prospects rather than an acquisition; no deal has been confirmed.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs REGAL Phase 3 AML trial reaching its prespecified 80th death event has triggered final analysis, with topline results expected this quarter. Traders are divided over whether GPS improved survival: bullish holders see the pending readout as a major catalyst, while bears question the efficacy case, and the share-price decline has intensified debate about selling pressure and alleged short activity.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is drawing attention after a sharp Nasdaq selloff tied to weakness in technology and semiconductor stocks, with traders debating whether concerns about AI spending and earnings justify more downside or whether the decline is an oversold dip to buy. The late-session rebound prompted some dip-buying optimism, but bearish traders continued to warn that the correction may not be over.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 76,874.98691422 USD and is down -4.82 over the last 24 hours. It is currently trading on 12773 active market(s) with $58,826,736,014.03 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

A reported major Binance security breach and temporary withdrawal suspension have fueled Bitcoin selling and concerns about crypto exchange security. Traders disagree over whether the incident signals broader risk or is isolated to Binance, with some viewing the pullback as a buying opportunity and others warning of further downside.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Precigens PAPZIMEOS commercial launch and stronger-than-expected quarterly results, including a move to profitability, are driving bullish discussion about its growth prospects. Traders also debate whether potential INO-3107 competition could challenge PAPZIMEOS and whether heavy short interest is amplifying the stocks moves.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is caught in a broader technology and semiconductor selloff as traders question whether massive AI infrastructure spending will generate adequate returns, with mixed Amazon and Intel results adding to sector concerns. The community is split between warnings that the AI trade may be overstretched and dip buyers who view the decline as a temporary pullback while AI demand remains strong.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

A strong third-quarter earnings beat, supported by growth in Eylea HD and Sanofi collaboration revenue tied to Dupixent, has driven a sharp move higher in REGN. Traders are broadly cheering the results and breakout, while some are watching for a pullback after the rally.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins steep selloff ahead of its quarterly report is fueling concern about slowing ad growth, analyst target cuts, and weakness across advertising-related stocks. Traders debate whether the decline reflects deteriorating prospects or has overshot the companys growth and cash-generation fundamentals, with earnings seen as a key test.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Thank You For all the love and support!
I hope my daily post regarding $NIFTY50.NSE $NIFTYBANK.NSE $NIFTYFINSERVICE.NSE  and FII and DII Data is helping you....and I hope everyone doing well...

We all can see the fear in the market as in $NIFTYMIDCAP100.NSE $NIFTYSMLCAP100.NSE 
Are coming down 
We all have some question in our mind whether to buy the stocks or sell our holding in stocks....for that I am ready to give any question you ask related to the market...

JOIN a special @StocktwitsIndia AMA- share your queries i will personally address each one

Bala Yogesh

Stocktwits India

Neha Gupta

NABANITA Chakraborty

Curious to know what lies ahead for your fav stocks? Here&#39;s @NawabiTrader hosting an AMA and sharing his views on stocks and sectors. Drop your queries in his comments below 👇 
 
$NIFTY50.NSE $NIFTYBANK.NSE $ASK.P

StockTwits Web

StockTwits For Android 

NSE Indices National Stock Exchange Index Nifty Financial Services Index

NIFTY SmallCap 100

NSE Indices NIFTY Midcap 100 Index

Thank You For all the love and support!
I hope my daily post regarding 

  and FII and DII Data is helping you....and I hope everyone doing well...

We all can see the fear in the market as in 

 
Are coming down 
We all have some question in our mind whether to buy the stocks or sell our holding in stocks....for that I am ready to give any question you ask related to the market...

JOIN a special 

 AMA- share your queries i will personally address each one

Nawabi Trader Ashish

@NawabiTrader @StocktwitsIndia what are your views on $TALBROAUTO.NSE $GUFICBIO.NSE and $BLS.NSE 

1. Fundamentally and
2. What can be the long term view

StockTwits for iOS

Talbros Automotive Components Ltd.

Gufic Biosciences Ltd.

BLS International Services Ltd

 

1. Fundamentally and
2. What can be the long term view

Roopak Agarwal

@NawabiTrader @StocktwitsIndia Please share your future outlook on $URJA.NSE and $ITC.NSE.

Urja Global Ltd

Samridhi Goel

@NawabiTrader @StocktwitsIndia can I buy HDFC for short term target 1500

 can I buy HDFC for short term target 1500

Pvpkumar

@NawabiTrader @StocktwitsIndia star cement at 172 book profit or hold

Ansh khandelwal

@NawabiTrader @StocktwitsIndia What&#39;s your thoughts on $BLS.NSE and $BEL.NSE

Bharat Electronics Ltd.

Karthik Hegde

@NawabiTrader @StocktwitsIndia long term view on $JTLIND.NSE and $NRBBEARING.NSE

NRB Bearings Ltd.

JTL Industries Ltd

Sarun Siby

@NawabiTrader @StocktwitsIndia  what about eidparry cn I hold it or sell????

  what about eidparry cn I hold it or sell????

khandre vish

@NawabiTrader @StocktwitsIndia I can hold $EMIL.NSE till 2025 ? Buy price 217.20

Electronics Mart India Ltd.

Abdul Rahim

@NawabiTrader @StocktwitsIndia what about $SUZLON.NSE  ?

Suzlon Energy Ltd.

@abdul02 @StocktwitsIndia you can hold it with the SL below 29.80 as 30-33 is support area also with 200 EMA support on Daily chart....

 you can hold it with the SL below 29.80 as 30-33 is support area also with 200 EMA support on Daily chart....

@abdul02 @StocktwitsIndia took support from 200 EMA on daily chart but it will come in positive territory after crossing 209 only...for  long term you can keep SL @ 200EMA which is near 169

 took support from 200 EMA on daily chart but it will come in positive territory after crossing 209 only...for  long term you can keep SL @ 200EMA which is near 169

@kanthvk @StocktwitsIndia what is your buy price sir???

@SarunSiby @StocktwitsIndia 
 $JTLIND.NSE chart is not looking good if it crosses 210 then only it will start its upward journey.....for long term you can keep SL of 138 on weekly closing basis.... 
and $NRBBEARING.NSE 194-246 is buying zone for this you can add here more if you like but only if you see structural change on chart..... bullish for long term

 chart is not looking good if it crosses 210 then only it will start its upward journey.....for long term you can keep SL of 138 on weekly closing basis.... 
and 

 194-246 is buying zone for this you can add here more if you like but only if you see structural change on chart..... bullish for long term

@KarthikHegde @StocktwitsIndia  
$BLS.NSE it is in its buying zone according to fib retracement it will only be bad if it cross below 280 on weekly time frame till then you can hold...long term view bullish 
$BEL.NSE if you are in profit you can book or you can keep sl of 170 and stay invested for long term ......135-151 is buying zone for long term.....

 it is in its buying zone according to fib retracement it will only be bad if it cross below 280 on weekly time frame till then you can hold...long term view bullish 


 if you are in profit you can book or you can keep sl of 170 and stay invested for long term ......135-151 is buying zone for long term.....

@khandelwalJi @StocktwitsIndia keep the SL of 180 and hold it as buying came from a support area your buying price is good sir

 keep the SL of 180 and hold it as buying came from a support area your buying price is good sir

@NawabiTrader @StocktwitsIndia $BLS.NSE Avg price 366
$BEL.NSE Avg price 193

😒 Currently both stocks locked!

 Avg price 193

😒 Currently both stocks locked!

@Pvpkumar @StocktwitsIndia yes you can buy but you need to have a tight SL @1420

 yes you can buy but you need to have a tight SL @1420

@Samridhigoel @StocktwitsIndia  
$URJA.NSE i prefer to avoid this kind of stock if you want to buy, buy it near 9.5-12...chart is not good for this 
 
$ITC you can hold it and if dip comes you can add also near 370.... bullish for long term

ITC Holdings Corp.

 i prefer to avoid this kind of stock if you want to buy, buy it near 9.5-12...chart is not good for this 
 


 you can hold it and if dip comes you can add also near 370.... bullish for long term

@KarthikHegde @StocktwitsIndia  
for $BLS 290-305 is crucial area keep an eye on it till then hold  
$BEL.NSE is good stock for long term and you should keep the SL of 170

  
for $BLS 290-305 is crucial area keep an eye on it till then hold  


 is good stock for long term and you should keep the SL of 170

@NawabiTrader @StocktwitsIndia Thanks for your inputs:)

@KarthikHegde @StocktwitsIndia  
happy to help sir

@NawabiTrader @StocktwitsIndia Thank you for the insight.

@NawabiTrader @StocktwitsIndia $sir 633 buy price